Tag Archives: This

AstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer

AstraZeneca is still stinging from Imfinzi’s combo flop in non-small cell lung cancer, but it’s already staring down another defeat. On Friday, the British drugmaker said the immuno-oncology drug had failed to show it could extend the lives of patients with recurrent or metastatic head and neck cancer whose disease has worsened after chemo. The… Read More »

I'm a Brain Doctor, and This Is What I Do to Prevent Alzheimer's

Despite the investment of hundreds of millions of dollars over the past several decades on the part of pharmaceutical companies, we still don’t have any meaningful treatment for Alzheimer’s disease. In fact, in a recent extensive study just published in the Journal of the American Medical Association, the two most commonly prescribed medications for Alzheimer’s… Read More »